Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
Sequenom, engaged in a hail Mary legal effort to protect a patent previously invalidated by legal action, confirmed this week that…
From - Laboratory Industry Report
The Alabama-based Kailos Genetics and the Huntsman Cancer Institute at the University of Utah have received a $2.4 million grant from the…
From - Laboratory Industry Report
A prominent dermatopathology laboratory in Dallas has been implicated in a CBS News investigation regarding potential fraudulent billing of the Tricare insurance program for…